3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Genitourinary
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Paraganglioma, Extra-Adrenal
1
Pancreatic Neoplasms
1
Neoplasms
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
pembrolizumab
39
Gemcitabine
30
Nivolumab
15
Cetuximab
13
Carboplatin
13
Cyclophosphamide
12
Cisplatin
12
Irinotecan
10
Docetaxel
10
130-nm albumin-bound paclitaxel
10
Trastuzumab
8
Magnetic Resonance Spectroscopy
8
fludarabine
7
aldesleukin
7
Paclitaxel
7
Drug Therapy
7
Bevacizumab
7
Taxes
6
Specimen Handling
6
Fluorouracil
6
Capecitabine
6
Albumin-Bound Paclitaxel
6
sargramostim
5
Pemetrexed
5
Oxaliplatin
5
Ipilimumab
5
spartalizumab
4
durvalumab
4
Standard of Care
4
Radiotherapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
temsirolimus
×
Thoracic
×
Clear all
NCT02423954
2018-07-02
NivoPlus
Western Regional Medical Center
Phase 1/2
Terminated
33 enrolled